A5069523333- Psoriasis: Treatment and Pathogenesis
- Polyomavirus and related diseases
- Autoimmune Bullous Skin Diseases
- Full-Duplex Wireless Communications
- Drug-Induced Adverse Reactions
- Cutaneous lymphoproliferative disorders research
- Dermatology and Skin Diseases
- Antenna Design and Analysis
- Cancer Immunotherapy and Biomarkers
- Urticaria and Related Conditions
- Nonmelanoma Skin Cancer Studies
- Cutaneous Melanoma Detection and Management
- Hair Growth and Disorders
- Acne and Rosacea Treatments and Effects
- Autoimmune and Inflammatory Disorders
- Eosinophilic Disorders and Syndromes
- Tumors and Oncological Cases
- Cancer and Skin Lesions
- Health Systems, Economic Evaluations, Quality of Life
- Autoimmune and Inflammatory Disorders Research
- Cytomegalovirus and herpesvirus research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Vascular Tumors and Angiosarcomas
- Herpesvirus Infections and Treatments
- Digital Imaging in Medicine
Stanford University
2020-2024
Palo Alto University
2021-2024
VA Palo Alto Health Care System
2021-2023
Loma Linda University
2023
University of California, Riverside
2023
University of California, Los Angeles
2017-2021
Stanford Medicine
2021
Psoriasis Association
2021
University of Illinois Chicago
2013
The risk of subsequent primary cancers after a diagnosis cutaneous Merkel cell carcinoma (MCC) is not well established.
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a 40% recurrence rate, lacking effective prognostic biomarkers and surveillance methods. This prospective, multicenter, observational study aimed to evaluate circulating tumor DNA (ctDNA) as biomarker for detecting MCC recurrence.
Pityriasis rubra pilaris (PRP) is a rare, difficult to treat papulosquamous disorder that responds variably retinoids and immunosuppression. Successful use of biologics for treating PRP has been described in the literature by case reports limited number series. To provide additional data, we retrospectively analyzed cases treated with at our institution. We identified seven patients clear diagnosis adalimumab, etanercept, and/or ustekinumab institution from January 1, 2014 April 2017. Six...
In the present study, we investigated anticancer effects of mitochondrial inhibitors, metaiodobenzylguanidine (MIBG), metformin and phenformin. 131I-MIBG has been used for scintigraphic detection targeted radiotherapy neuroblastoma (NB), a pediatric malignancy. Non-radiolabeled MIBG reported to be cytotoxic NB cells in vitro vivo. However, mechanisms behind its growth suppressive have not yet fully elucidated. Metformin phenformin are diabetes medications that being considered therapeutics....
Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra PilarisPityriasis rubra pilaris (PRP) is a rare papulosquamous disorder that normally manifests with hyperkeratotic follicularbased papules, scaling erythematous plaques areas of sparing, palmoplantar keratoderma. 1 Considerable heterogeneity exists the clinical features PRP.Not all patients experience progression to erythroderma, PRP sometimes associated seronegative arthritis. 1,2 The prevalence...
To the Editor: Prurigo pigmentosa (PP) is an inflammatory skin disease characterized by a sudden eruption of pruritic, erythematous papules in reticular pattern followed hyperpigmentation.1Nagashima M. pigmentosa--clinical observations our 14 cases.J Dermatol. 1978; 5: 61-67https://doi.org/10.1111/j.1346-8138.1978.tb01049.xCrossref PubMed Scopus (95) Google Scholar In recent years, PP has been anecdotally associated with ketogenic diet.2Delaleu J. Grynberg-Laloum E. Moguelet P. et al.Prurigo...
Chronic skin ulcers in patients with suspected pyoderma gangrenosum can, on closer inspection and further workup, have a different cause. Recognition of key features clinical examination such as the presence atrophie blanche is to avoid misdiagnosis its subsequent treatment high-dose corticosteroids other immunosuppressive medications.
Five hundred ten women identified as SMW (lesbian [20.4%], bisexual [66.9%], something else [12.7%]) and 6378 heterosexual (response rate to SPB questionnaire: 92.3% [6359/6888]).Compared women, were less likely use sunscreen (aOR 0.77, 95% CI 0.61-0.99),but reported similar long-sleeve clothing shade-seeking.SMW spent more time outdoors on workdays (difference 29.1 minutes, 19.4-38.9)and nonworkdays 24.7 13.8-35.6).SMW also had an increased odds of spending at least 3 hours during 1.95,...
Purpose Ruxolitinib (Jakafi) is a Janus kinase 1 and 2 small molecule inhibitor that the Food Drug Administration approved for myelofibrosis polycythemia vera. It has been expanded to off-label treatment variety of dermatologic conditions, with several clinical trials ongoing. A review available studies cases uses was performed guide clinicians seeking evidence on efficacy this disorders. Materials Methods PubMed/MEDLINE, EMBASE, Scopus, ClinicalTrials.gov databases were searched term...